RT @vennetilab: So happy to see our finding of H3K27me3 loss as a biomarker for PFA ependymomas (https://t.co/jKq0JW1Oly) reproduced across…
RT @vennetilab: So happy to see our finding of H3K27me3 loss as a biomarker for PFA ependymomas (https://t.co/jKq0JW1Oly) reproduced across…
RT @vennetilab: So happy to see our finding of H3K27me3 loss as a biomarker for PFA ependymomas (https://t.co/jKq0JW1Oly) reproduced across…
RT @vennetilab: So happy to see our finding of H3K27me3 loss as a biomarker for PFA ependymomas (https://t.co/jKq0JW1Oly) reproduced across…
RT @vennetilab: So happy to see our finding of H3K27me3 loss as a biomarker for PFA ependymomas (https://t.co/jKq0JW1Oly) reproduced across…
So happy to see our finding of H3K27me3 loss as a biomarker for PFA ependymomas (https://t.co/jKq0JW1Oly) reproduced across 6 european labs. https://t.co/h19INTGUPL @CERNfoundation @postdockin @MottChildren @UMichPath @UMRogelCancer
@Pajtler_Lab @NeuroOnc @CBTRC1 @SIOPEurope Many congratulations on a beautiful paper! So happy to see that you are able to reproduce our findings from https://t.co/9WnsWHfdRI
@neuropathology I learned something. https://t.co/wT0D1QX03X
RT @NeurosurgeryNM: Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group https://t.co/6jFk3oNPG9 @BioMedCentral…
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group https://t.co/6jFk3oNPG9 @BioMedCentral @CraigHorbinski
RT @ActaNeuropathol: A specific and convenient diagnostic marker for PFA #ependymoma: loss of #H3K27me3. #neurooncology #histone #H3K27 ht…
RT @ActaNeuropathol: A specific and convenient diagnostic marker for PFA #ependymoma: loss of #H3K27me3. #neurooncology #histone #H3K27 ht…
RT @ActaNeuropathol: A specific and convenient diagnostic marker for PFA #ependymoma: loss of #H3K27me3. #neurooncology #histone #H3K27 ht…
RT @ActaNeuropathol: A specific and convenient diagnostic marker for PFA #ependymoma: loss of #H3K27me3. #neurooncology #histone #H3K27 ht…
RT @pathowitter: H3K27me3 IHC demonstrates global reduction in group-A childhood posterior fossa ependymoma https://t.co/u56340RvDW
Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa… https://t.co/Axk8xb7IYr
RT @pathowitter: H3K27me3 IHC demonstrates global reduction in group-A childhood posterior fossa ependymoma https://t.co/u56340RvDW
H3K27me3 IHC demonstrates global reduction in group-A childhood posterior fossa ependymoma https://t.co/u56340RvDW
RT @ActaNeuropathol: A specific and convenient diagnostic marker for PFA #ependymoma: loss of #H3K27me3. #neurooncology #histone #H3K27 ht…
RT @ActaNeuropathol: A specific and convenient diagnostic marker for PFA #ependymoma: loss of #H3K27me3. #neurooncology #histone #H3K27 ht…
A simple and elegant approach to a potentially complex diagnosis. And the senior author was my senior fellow! #neuropath #PediPath https://t.co/I9ohozB8qB
#genomic analysis of brain tumours that grow from lining of ventricles in brain to better treat & know prognosis. #neuropath https://t.co/xOQ8ymDbEw
RT @NatRevNeurol: Immunohistochemical analysis of H3K27me3 reliably differentiates high-risk and low-risk ependymomas in children https://t…
RT @ActaNeuropathol: A specific and convenient diagnostic marker for PFA #ependymoma: loss of #H3K27me3. #neurooncology #histone #H3K27 ht…
RT @ActaNeuropathol: A specific and convenient diagnostic marker for PFA #ependymoma: loss of #H3K27me3. #neurooncology #histone #H3K27 ht…
RT @NatRevNeurol: Immunohistochemical analysis of H3K27me3 reliably differentiates high-risk and low-risk ependymomas in children https://t…
Immunohistochemical analysis of H3K27me3 reliably differentiates high-risk and low-risk ependymomas in children https://t.co/pgNici1Svj
RT @ActaNeuropathol: A specific and convenient diagnostic marker for PFA #ependymoma: loss of #H3K27me3. #neurooncology #histone #H3K27 ht…